Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC | $185.24M | $44.95M | $8.10M | $3.75M | $0.09 | 1,299.50% | N/A | N/A | N/A | 2024-08-01 | |
| TGTX | TG THERAPEUTICS INC | $2.52B | $289.33M | $53.85M | $41.20M | $0.29 | 3,275.73% | 352.80% | N/A | N/A | 2024-07-30 | |
| SRPT | SAREPTA THERAPEUTICS INC | $12.27B | $1.40B | $91.13M | $16.90M | $0.41 | 43.83% | 34.11% | N/A | N/A | 2024-06-06 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.67B | $617.51M | $237.47M | $137.70M | $2.35 | 30.92% | N/A | -26.33% | N/A | 2024-07-30 | |
| INCY | INCYTE CORP | $12.98B | $3.77B | $1.11B | $745.44M | $3.33 | 8.58% | 13.53% | 128.08% | 22.65% | 2024-06-10 | |
| CORT | CORCEPT THERAPEUTICS INC | $3.14B | $523.53M | $122.89M | $117.19M | $1.15 | 26.51% | 15.17% | 30.68% | 11.75% | 2024-07-31 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.91B | $411.35M | $122.26M | $65.12M | $0.60 | 60.38% | 99.71% | -36.84% | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $5.64B | $862.99M | $495.45M | $318.80M | $2.45 | 22.41% | 37.13% | 84.21% | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $16.38B | $2.24B | $983.33M | $798.86M | $1.79 | -5.11% | N/A | 141.89% | N/A | 2024-06-06 | |
| GMAB | GENMAB A | $18.65B | $2.56B | N/A | $784.32M | $1.20 | 15.36% | 42.16% | 3.78% | 29.55% | 2024-06-03 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $14.25B | $2.47B | $359.85M | $205.46M | $1.09 | 13.74% | 10.23% | 194.59% | N/A | 2024-07-29 | |
| MNKD | MANNKIND CORP | $1.27B | $224.60M | $45.65M | $8.49M | $0.04 | 74.92% | 39.95% | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.63B | $3.84B | $1.16B | $330.79M | $5.23 | 2.81% | 14.48% | N/A | -8.51% | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $185.72M | $226.63M | $41.45M | $15.38M | $0.33 | -3.59% | -4.38% | 230.00% | N/A | 2024-06-18 | |
| TECH | BIO-TECHNE CORP | $12.16B | $1.15B | $354.14M | $203.00M | $1.27 | 2.73% | 10.44% | -26.59% | 9.63% | ||
| BNTX | BIONTECH SE | $23.92B | $2.94B | $397.96M | $121.51M | $0.52 | -77.65% | N/A | -98.13% | N/A | ||
| EXEL | EXELIXIS INC | $6.32B | $1.85B | $312.76M | $205.05M | $0.64 | 10.98% | 16.63% | 33.33% | -21.67% | 2024-07-30 | |
| MDXG | MIMEDX GROUP INC | $1.06B | $334.51M | $50.76M | $74.16M | $0.52 | 19.20% | -0.41% | N/A | N/A | 2024-06-05 | |
| REGN | REGENERON PHARMACEUTICALS INC | $108.00B | $13.10B | $4.55B | $3.86B | $36.12 | 5.90% | 21.21% | -7.53% | 9.99% | 2024-06-14 | |
| UTHR | UNITED THERAPEUTICS CORP | $12.20B | $2.50B | $1.49B | $1.05B | $22.36 | 26.09% | 9.30% | 40.98% | N/A | 2024-06-25 | |
| NVO | NOVO NORDISK A S | $610.11B | $35.14B | $17.67B | $12.85B | $2.87 | 28.21% | 15.46% | 45.69% | 19.19% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.